Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Adam Scott Levy

CFO at Mineralys Therapeutics, Inc. (MLYS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 13SEC MLYSMineralys Therapeutics, Inc. Sell Plan 10,7588,638 held (−55%) $32.14 $346K -27.3%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 1,015137,905 held (−1%) $42.00 $43K -44.4%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 11,295126,610 held (−8%) $41.87 $473K -44.2%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 1,561125,049 held (−1%) $42.68 $67K -45.2%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 12,952112,097 held (−10%) $41.65 $539K -43.9%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 8,485103,612 held (−8%) $42.34 $359K -44.8%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 4,14299,470 held (−4%) $43.50 $180K -46.3%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 8,45691,014 held (−9%) $45.18 $382K -48.3%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 38,90052,114 held (−43%) $45.93 $1.8M -49.1%
Nov 13SEC MLYSMineralys Therapeutics, Inc. Sell 32,71819,396 held (−63%) $46.88 $1.5M -50.1%
Oct 15SEC MLYSMineralys Therapeutics, Inc. Sell Plan 7,366120,257 held (−6%) $41.90 $309K -44.2%
Oct 15SEC MLYSMineralys Therapeutics, Inc. Sell Plan 3,392116,865 held (−3%) $42.26 $143K -44.7%
  • Sell

    CFO Adam Scott Levy sold $346K of MLYS at $32.14 — cuts the stake by 55%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Adam Scott Levy sold $1.8M of MLYS at $45.93 — cuts the stake by 43%.

  • Sell

    CFO Adam Scott Levy sold $1.5M of MLYS at $46.88 — cuts the stake by 63%.

  • Sell

    CFO Adam Scott Levy sold $309K of MLYS at $41.90 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Adam Scott Levy sold $143K of MLYS at $42.26 — pre-scheduled 10b5-1 plan sale.